NTLA reports better-than-expected first-quarter 2025 results. The company provides updates on its pipeline candidates. Shares rise.

Discover Q1 2025 earnings insights from Intellia Therapeutics (NTLA): Phase 3 progress, RMAT milestones, financial outlook, and competitive gene editing edge.

On track to complete enrollment of the global Phase 3 HAELO study in hereditary angioedema (HAE) in the third quarter of 2025Dosed first patient in the global Phase 3 MAGNITUDE-2 study evaluating nexi ...

Intellia will present additional data from the ongoing Phase 1/2 study in an oral presentation at the European Academy of ...

CRISPR Therapeutics and Intellia face 2025 volatility, but CRSP’s strong cash and launches make it more attractive than NTLA. Learn more on CRSP and NTLA stocks here.

Although Sony claims its new NEX-5 as the world’s smallest and lightest interchangeable-lens camera, this can only apply to the camera body itself, which is similar in size and shape to Sony’s ...

But the sale also features discounts on other interesting gadgets, including the Nex Playground game console. Prominently featured in one of the top slots on Amazon's sale hub, the Nex Playground ...

Want to find out if your device is compatible with Fortnite Mobile on Android? You’ve come to the right place! Here, you’ll find a list of all the Android phones that are compatible with Epic ...

Vivo is gearing up to launch the Vivo X200 FE model in the Indian market as per reports. It was earlier mentioned that Vivo is going to bring both the X200 Pro Mini and the top-tier X200 Ultra models ...

The Vivo T4 5G is set to go on sale in India for the first time today. To recall, the Vivo T4 5G was unveiled in India earlier this month as a rebranded version of the iQOO Z10 5G. The Vivo T4 5G ...

We are writing to set the record straight in response to the Vivo group’s recent press releases, lawsuits and other actions against SINOVAC and the Board, particularly those related to the Board ...